Corbus Pharmaceuticals (NASDAQ:CRBP) Downgraded by StockNews.com
StockNews.com cut shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a report published on Wednesday. Other equities analysts have also issued research reports about the stock. Royal Bank of Canada increased their target price on shares of Corbus Pharmaceuticals from $77.00 to $82.00 and gave the […]
More Stories
Hims & Hers Health (NYSE:HIMS) Shares Gap Down – Time to Sell?
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) gapped down before the market opened on Tuesday...
Trump May Not Need to Pull Trigger on Tariffs, Economist Says
By John Haughey Economists near-universally warn that President-elect Donald Trump’s pledge to impose “across-the-board” 20-percent tariffs on imports will trigger...
Second Half Financial Partners LLC Buys Shares of 3,546 RTX Co. (NYSE:RTX)
Second Half Financial Partners LLC purchased a new position in RTX Co. (NYSE:RTX – Free Report) in the 3rd quarter,...
B. Metzler seel. Sohn & Co. Holding AG Purchases New Shares in UnitedHealth Group Incorporated (NYSE:UNH)
B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report)...
Barnes Group Inc. (NYSE:B) Short Interest Update
Barnes Group Inc. (NYSE:B – Get Free Report) saw a significant increase in short interest during the month of October....
Burlington Stores, Inc. (NYSE:BURL) Short Interest Up 5.8% in October
Burlington Stores, Inc. (NYSE:BURL – Get Free Report) was the recipient of a large growth in short interest during the...